According to Standard BioTools's latest financial reports the company's current revenue (TTM) is $0.10 B. In 2022 the company made a revenue of $97.94 M a decrease over the years 2021 revenue that were of $0.13 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.10 B | 8.57% |
2022 | $97.94 M | -24.99% |
2021 | $0.13 B | -5.47% |
2020 | $0.13 B | 17.83% |
2019 | $0.11 B | 3.79% |
2018 | $0.11 B | 10.82% |
2017 | $0.10 B | -2.4% |
2016 | $0.10 B | -8.95% |
2015 | $0.11 B | -1.5% |
2014 | $0.11 B | 63.6% |
2013 | $71.18 M | 36.02% |
2012 | $52.33 M | 22.09% |
2011 | $42.86 M | 27.73% |
2010 | $33.56 M |